rss
Br J Ophthalmol 1989;73:1015-1018 doi:10.1136/bjo.73.12.1015
  • Research Article

Ocular myasthenia gravis after D-penicillamine administration.

  1. L J Katz,
  2. R L Lesser,
  3. J R Merikangas and
  4. J P Silverman
  1. William and Anna Goldberg Glaucoma Service, Thomas Jefferson University, Philadelphia, PA 19107.

      Abstract

      A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis. Two weeks after she discontinued D-penicillamine her signs and symptoms cleared with no other treatment. Review of previous cases and possible immunological mechanisms are discussed.

      This Article

      1. Abstract
      2. PDF

      Services

      1. Email this link to a friend
      2. Alert me when this article is cited
      3. Alert me if a correction is posted
      4. Alert me when eletters are published
      5. Article Usage Statistics
      6. Similar articles in this journal
      7. Similar articles in Web of Science
      8. Similar articles in PubMed
      9. Add article to my folders
      10. Download to citation manager
      11. Request permissions

      Responses

      1. Submit a response
      2. No responses published

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
      View free sample issue >>

      Free archive
      The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.